Ontario-based Crescita Therapeutics Inc. completed a rights offering to raise C$3.7 million in gross proceeds.
The company, which develops treatments for skin diseases, will issue 7,001,603 common shares priced at 53 Canadian cents apiece.
The company plans to use the net proceeds for working capital and for business development initiatives.
